摘要:
Formulations d'aérosol de solution pharmaceutique comprenant béclométhasone 17,21 dipropionate, éthanol ainsi qu'un propulseur choisi dans le groupe constitué de 1,1,1,2-tétrafluoroéthane, 1,1,1,2,3,3,3-heptafluoropropane, ainsi qu'un mélange de ceux-ci.
摘要:
Formulations pharmaceutiques d'un aérosol en suspension, contenant une dose thérapeutique efficace d'un médicament, et du HFC 134a, du HFC 227, ou un mélange de ceux-ci.
摘要:
Pharmaceutical suspension aerosol formulations using one or more perfluorinated sulfonamido alcohol phosphate esters as surface-active dispersing agents and 1,1,1,2-tetra-fluoroethane, 1,1,1,2,3,3,3-heptafluoropropane, or a mixture thereof, as the propellant.
摘要:
Compositions pour aérosol contenant des suspensions pharmaceutiques utilisant un ou plusieurs esters de phosphate d'alcool sulfonamidoperfluorurés utilisés comme agents dispersants tensio-actifs et 1,1,1,2-tetra-fluoroéthane, 1,1,1,2,3,3,3-heptafluoropropane, ou un mélange de ceux-ci, comme gaz propulseur.
摘要:
Methods, compounds, and medicinal formulations utilizing biocompatible polymers for delivery of a drug, particularly for solubilizing, stabilizing and/or providing sustained release of drug from topical, implantable, and inhalation systems. Many of the methods, compounds, and medicinal formulations are particularly suitable for oral and/or nasal inhalation and use polymers of the formula -[X-R1-C(O)]- wherein each R1 is an independently selected organic group that links the -X- group to the carbonyl group, and each X is independently oxygen, sulfur, or catenary nitrogen.
摘要:
Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.
摘要:
Methods, compounds, and medicinal formulations utilizing biocompatible polymers for delivery of a drug, particularly for solubilizing, stabilizing and/or providing sustained release of drug from topical, implantable, and inhalation systems. Many of the methods, compounds, and medicinal formulations are particularly suitable for oral and/or nasal inhalation and use polymers of the formula -[X-R -C(O)]- wherein each R is an independently selected organic group that links the -X- group to the carbonyl group, and each X is independently oxygen, sulfur, or catenary nitrogen.